TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
JK Biostatistics AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 1,911 | 1,982 | 1,935 |
Financial expenses | 1 | 2 | 0 |
Earnings before taxes | 103 | 365 | 540 |
EBITDA | 125 | 367 | 498 |
Total assets | 1,429 | 1,023 | 1,055 |
Current assets | 1,162 | 895 | 224 |
Current liabilities | 502 | 170 | 246 |
Equity capital | 927 | 853 | 809 |
- share capital | 67 | 67 | 73 |
Employees (average) | 3 | 3 | 2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 64.9% | 83.4% | 76.7% |
Turnover per employee | 637 | 661 | 968 |
Profit as a percentage of turnover | 5.4% | 18.4% | 27.9% |
Return on assets (ROA) | 7.3% | 35.9% | 51.2% |
Current ratio | 231.5% | 526.5% | 91.1% |
Return on equity (ROE) | 11.1% | 42.8% | 66.7% |
Change turnover | -81 | 204 | 101 |
Change turnover % | -4% | 11% | 6% |
Chg. No. of employees | 0 | 1 | 0 |
Chg. No. of employees % | 0% | 50% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.